Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Evin H. Gulbahce"'
Autor:
Diane M. Wilcock, Kristina H. Moore, Leslie Rowe, Jonathan Mahlow, Jolanta Jedrzkiewicz, Allison S. Cleary, Lesley Lomo, Ana L. Ruano, Maarika Gering, Derek Bradshaw, Meghan Maughan, Phuong Tran, Jesse Burlingame, Richard Davis, Kajsa Affolter, Daniel J. Albertson, Parisa Adelhardt, Jong Take Kim, Joshua F Coleman, Georgios Deftereos, Evin H. Gulbahce, Deepika Sirohi
Publikováno v:
Archives of Pathology & Laboratory Medicine.
Context.— Quantitative imaging is a promising tool that is gaining wide use across several areas of pathology. Although there has been increasing adoption of morphologic and immunohistochemical analysis, the adoption for evaluation of fluorescence
Publikováno v:
Cancer Research. 80:P2-08
Background: About 50% of breast cancers (BrCa) occur in women over the age of 65. Although chemotherapy improves survival in patients with estrogen receptor (ER) positive BrCa, benefits of chemotherapy in older woman must be weighed against the risks
Autor:
Diane M. Wilcock, Valarie McMurtry, Joshua F. Coleman, Jong Taek Kim, Parisa Khalili, Georgios Deftereos, Daniel Albertson, Evin H. Gulbahce, Ting Liu, Deepika Sirohi
Publikováno v:
International journal of surgical pathology. 30(7)
Background: Identification of MDM2 amplification by fluorescence in situ hybridization is an important diagnostic tool for evaluation of adipocytic neoplasms. Rarely, neoplasms can show increased copies of MDM2 and CEP12 probes (polysomy) without amp
Autor:
Rachel E. Factor, Yulan Jin, Kevin Van Smaalen, Xiaoxian Li, Evin H Gulbahce, Frank Schneider
Publikováno v:
American Journal of Clinical Pathology. 151:504-510
OBJECTIVES Accurate evaluation of human epidermal growth factor receptor 2 (HER2) in breast cancer is critical. METHODS HER2 fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) tests were performed on 52 cases using a US Food and
Autor:
Justin E. Caron, Rachel E. Factor, Katherine B. Geiersbach, Evin H Gulbahce, Erinn Downs-Kelly, Rachel L. Stewart
Publikováno v:
Modern Pathology. 30:1561-1566
The 2013 American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) recommendations for HER2 testing contain a recommendation for pathologists with respect to invasive micropapillary carcinoma. The guidelines suggest that HER2
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 9, Iss 3, Pp 861-868 (2016)
Case Reports in Oncology, Vol 9, Iss 3, Pp 861-868 (2016)
Introduction: Phyllodes tumors (PTs) are rare fibroepithelial tumors of the breast which are classified as benign, borderline, or malignant. Malignant PTs account for Case: A 66-year-old female presented with a large breast mass. Biopsy identified ma
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 31(4)
Reply to Commentary on ‘HER2 immunohistochemical and fluorescence in situ hybridization discordances in invasive breast carcinoma with micropapillary features’
Autor:
Eric M. Johnson, Evin H Gulbahce
Publikováno v:
Journal of Clinical Oncology. 35:e23188-e23188
e23188 Background: Accurate HER2 testing is expected to identify patients who will benefit from HER2 directed therapy (HDT) minimizing false positive and negatives. Like many biologic processes, HER2 protein expression and gene copy numbers are a con
Autor:
Katherine A, Ward, Phillip M, Ecker, Rebekah R, White, Tanya E, Melnik, Evin H, Gulbahce, Mark S, Wilke, Omar P, Sangueza
Publikováno v:
Dermatology online journal. 16(4)
The term angiosarcoma, encompasses several neoplasms, all of which exhibit a malignant process derived from endothelial cells of the vessels. The most common form of angiosarcoma is highly aggressive, often fatal, and usually affects the head and nec